FDA Inspection 1279979 — Biowy Corporation
The FDA completed an inspection of Biowy Corporation on August 8, 2025 in Lake Forest, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 8, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lake Forest, CA (United States)